Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Exploring the Vertical Transmission of Exosomes in Diagnostic and Therapeutic Targets for Pregnancy Complications

Bhagat S., Hanumanthappa R., Bhokare K., Datta N., Vastrad N., David M.

Narrative Review on Immune Modulation, published in ACS Biomater Sci Eng (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
ACS Biomater Sci Eng (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40511890
PMCID
PMC12421513
DOI
10.1021/acsbiomaterials.5c00119
Citations
2

Abstract (original English)

During pregnancy, the mother-placenta relationship involves intricate and dynamic exchanges. Over the course of gestation, the maternal body encounters numerous fetal materials secreted by the placenta, such as hormones, growth factors, and extracellular vesicles like exosomes. These exosomes are carriers of key biomolecules, including proteins, lipids, nucleic acids (DNA), and microRNA (miRNA), capable of influencing maternal cellular activity. Although the exact functions of placental exosomes during pregnancy remain under investigation, existing research indicates that they contribute significantly to normal placental growth and maternal immune tolerance, both of which are vital for sustaining a healthy pregnancy. The involvement of exosomes in the etiology and progression of pregnancy complications is also under investigation. Variations in the quality and quantity of placenta-derived exosomes, their concentration in maternal plasma, and their composition and bioactivity have been linked to complications such as gestational diabetes, preeclampsia, and maternal infections. There is considerable interest not only in understanding the role of placenta-derived exosomes in both normal and complicated pregnancies but also in their potential as biomarkers and therapeutic targets. Progress in this field depends on using specific and well-characterized methodologies and techniques t

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
PlacentaAnimalsHumansPregnancy ComplicationsMicroRNAsPregnancyFemaleExosomesBiomarkers

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research